Tata India Pharma & Healthcare Fund vs UTI Healthcare Fund compare
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
UTI Healthcare Fund - Regular Plan - Growth Option
Chart Comparison
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Fund | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹1208 Cr | ₹1187 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹100 | ₹500 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 28 Dec 2015 | 30 Jul 2005 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | Nifty Pharma TRI | BSE Healthcare |
| Turn Over | 26.49% | 28% |
| Expense Ratio | 2.14 | 2.25 |
| Manager | Meeta Shetty | Kamal Gada |
| ISIN Code | INF277K016A9 | INF789F01695 |
| Exits Load | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 | UTI Healthcare Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| 1 Month | -3.04% | -2.99% |
| 6 Month | 9.88% | 13.17% |
| 1 Year | 27.65% | 31.36% |
| 3 Year | 20.65% | 20.3% |
| 5 Year | 25.56% | 25.72% |
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| 6 Month | - | - |
| 1 Year | 19.99% | 24.85% |
| 3 Year | 29.34% | 30.93% |
| 5 Year | 23.84% | 24.08% |
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| 1 Year | 6.67% | 10.93% |
| 3 Year | 17.46% | 15.88% |
| 5 Year | 14.22% | 14.02% |
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Standard Deviation | 14.23% | 14.3% |
| Sharp | 0.74% | 0.62% |
| Beta | 0.9% | 0.94% |
| Alpha | 2.85% | 0.78% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Name | Meeta Shetty | Kamal Gada |
| Total AUM | ₹17847 Cr | ₹870 Cr |
| Fund Manage | 5 | 1 |
| Tata India Pharma & Healthcare Fund-Regular Plan-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
| Scheme Name |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Others | 5.39 | 1.53 |
| Small Cap | 23.46 | 39.04 |
| Large Cap | 40.33 | 32.81 |
| Mid Cap | 30.82 | 26.59 |
| Scheme Name |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Others | 5.39 | 1.53 |
| Pharmaceuticals & Biotechnology | 76.28 | 75.33 |
| Healthcare Services | 14.31 | 21.22 |
| Fertilizers & Agrochemicals | 0.83 | - |
| Chemicals & Petrochemicals | 0.39 | - |
| Insurance | 2.14 | 1.04 |
| Retailing | 0.66 | - |
| Healthcare Equipment & Supplies | - | 0.85 |
Top Comparisons
Mirae Asset Banking and PSU Fund Regular Growth Plan
3Y Returns5.72%
Axis Banking & PSU Debt Fund - Regular Plan - Growth option
3Y Returns6%
Kotak Money Market Scheme - (Growth)
3Y Returns6.67%
Kotak Money Market Scheme - (Growth)
3Y Returns6.67%
Aditya Birla Sun Life Asset Allocator FoF- Regular Plan - Growth Option
3Y Returns12.55%
Motilal Oswal Asset Allocation FOF- A- Regular Growth
3Y Returns12.56%
Franklin India Focused Equity Fund - Growth Plan
3Y Returns13.72%
DSP Focus Fund - Regular Plan - Growth
3Y Returns13.12%